Item 2. Unregistered Sales of Equity Securities
ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Recent
Sale of Unregistered Equity Securities
No
unregistered equity securities were issued during the period ended June 30, 2022 except for the 35,000 shares issued in connection with
services provided to the Company. In connection with the completion of the IPO we repaid the $2,000,000 Notes Payable and settled the
Contingent Stock liability by issuing 235,295 shares of common stock. Further, the Company issued 235,295 warrants to the Purchasers in
connection with the Note Purchase agreement.
Use
of Proceeds
On
April 13, 2022, our Registration Statement on Form S-1 (No. 333-263715) was declared effective by the SEC pursuant to which we issued
and sold an aggregate of 3,750,000 units, each consisting of one share of common stock and two warrants, to purchase one share of common
stock for each whole warrant, with an initial exercise price of $4.25 per share and a term of five years. In addition, we granted Aegis
Capital Corp., as underwriter a 45-day over-allotment option to purchase up to 15% of the number of shares included in the units sold
in the offering, and/or additional warrants equal to 15% of the number of Warrants included in the units sold in the offering, in each
case solely to cover over-allotments, which the Aegis Capital Corp. partially exercised with respect to 1,125,000 warrants on April 19,
2022. No payments for such expenses were made directly or indirectly to (i) any of our officers or directors or their associates, (ii)
any persons owning 10% or more of any class of our equity securities or (iii) any of our affiliates. There has been no material change
in the planned use of proceeds from our initial public offering from that described in the Prospectus.
25
ITEM
6. EXHIBITS
Exhibit
Number
Description
10.1
*
Employment
Agreement between the Company and Alan R. Blackman dated August 1, 2022.
31.1*
Certification
of Co-Chief Executive Officers (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange
Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*
Certification
of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities
Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**
Certification
of Co-Chief Executive Officers (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906
of the Sarbanes-Oxley Act of 2002.
32.2**
Certification
of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS
Inline
XBRL Instance Document
101.SCH
Inline
XBRL Taxonomy Extension Schema Document
101.CAL
Inline
XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
Inline
XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
Inline
XBRL Taxonomy Extension Label Linkbase Document
101.PRE
Inline
XBRL Taxonomy Extension Presentation Linkbase Document
104*
Cover
Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
*
Filed
herewith.
26
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized, on this 25 day of May, 2022.
SHARPS
TECHNOLOGY, INC.
August
15, 2022
/s/
Robert M. Hayes
Robert
M. Hayes
Chief
Executive Officer and Director
(Principal
Executive Officer)
August
15, 2022
/s/
Andrew R. Crescenzo
Andrew
R. Crescenzo
Chief
Financial Officer
(Principal
Financial Officer)
27
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.